Cargando…
THEIA™ development, and testing of artificial intelligence‐based primary triage of diabetic retinopathy screening images in New Zealand
AIM: To develop and evaluate an artificial intelligence triage system with high sensitivity for detecting referable diabetic retinopathy and maculopathy, while maintaining high specificity for non‐referable disease, for clinical implementation within the New Zealand national diabetic retinopathy scr...
Autores principales: | Vaghefi, E., Yang, S., Xie, L., Hill, S., Schmiedel, O., Murphy, R., Squirrell, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048953/ https://www.ncbi.nlm.nih.gov/pubmed/32794618 http://dx.doi.org/10.1111/dme.14386 |
Ejemplares similares
-
A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening program
por: Vaghefi, Ehsan, et al.
Publicado: (2022) -
Evaluation of the prevalence of non-diabetic eye disease detected at first screen from a single region diabetic retinopathy screening program: a cross-sectional cohort study in Auckland, New Zealand
por: Ramachandran, Nishanthan, et al.
Publicado: (2021) -
Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort
por: Lawrenson, J. G., et al.
Publicado: (2020) -
Towards implementation of AI in New Zealand national diabetic screening program: Cloud-based, robust, and bespoke
por: Xie, Li, et al.
Publicado: (2020) -
Approaches to screening for hyperglycaemia in pregnant women during and after the COVID‐19 pandemic
por: Meek, C. L., et al.
Publicado: (2020)